vs
Side-by-side financial comparison of Great Elm Group, Inc. (GEG) and Opus Genetics, Inc. (IRD). Click either name above to swap in a different company.
Opus Genetics, Inc. is the larger business by last-quarter revenue ($3.9M vs $3.0M, roughly 1.3× Great Elm Group, Inc.). On growth, Opus Genetics, Inc. posted the faster year-over-year revenue change (-10.2% vs -14.1%). Over the past eight quarters, Opus Genetics, Inc.'s revenue compounded faster (50.3% CAGR vs -4.6%).
Great Elm Group, Inc. is an alternative asset management firm that offers private credit products, real asset investment vehicles, and customized capital solutions for small and medium-sized enterprises. It primarily serves institutional investors and high-net-worth individuals across the North American market.
Opus Genetics, Inc. is a clinical-stage biotechnology company specializing in the development of targeted gene therapies for inherited retinal diseases. It focuses on addressing unmet medical needs for patients living with rare, vision-threatening ocular conditions, with operations centered on advancing accessible therapeutic candidates for global rare disease patient populations.
GEG vs IRD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.0M | $3.9M |
| Net Profit | $-16.5M | — |
| Gross Margin | 99.5% | — |
| Operating Margin | -140.6% | — |
| Net Margin | -549.6% | — |
| Revenue YoY | -14.1% | -10.2% |
| Net Profit YoY | -1507.1% | 53.0% |
| EPS (diluted) | $-0.50 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.0M | $3.9M | ||
| Q3 25 | $10.8M | $3.1M | ||
| Q2 25 | — | $2.9M | ||
| Q1 25 | $3.2M | $4.4M | ||
| Q4 24 | $3.5M | $4.3M | ||
| Q3 24 | $4.0M | $3.9M | ||
| Q2 24 | — | $1.1M | ||
| Q1 24 | $2.8M | $1.7M |
| Q4 25 | $-16.5M | — | ||
| Q3 25 | $-7.9M | $-17.5M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | $-4.5M | $-8.2M | ||
| Q4 24 | $1.2M | — | ||
| Q3 24 | $2.6M | $-7.5M | ||
| Q2 24 | — | $-7.8M | ||
| Q1 24 | $-3.1M | $-7.1M |
| Q4 25 | 99.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 86.9% | — | ||
| Q3 24 | 84.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -140.6% | — | ||
| Q3 25 | -34.5% | -269.9% | ||
| Q2 25 | — | -309.0% | ||
| Q1 25 | -79.6% | -227.2% | ||
| Q4 24 | -56.4% | — | ||
| Q3 24 | -50.0% | -207.1% | ||
| Q2 24 | — | -748.9% | ||
| Q1 24 | -67.1% | -450.5% |
| Q4 25 | -549.6% | — | ||
| Q3 25 | -73.3% | -566.9% | ||
| Q2 25 | — | -257.5% | ||
| Q1 25 | -140.1% | -187.5% | ||
| Q4 24 | 33.5% | — | ||
| Q3 24 | 66.1% | -194.6% | ||
| Q2 24 | — | -698.3% | ||
| Q1 24 | -111.2% | -415.3% |
| Q4 25 | $-0.50 | — | ||
| Q3 25 | $-0.24 | $-0.25 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | $-0.17 | $-0.24 | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.08 | $-0.29 | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | $-0.10 | $-0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.2M | $45.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $55.8M | $15.3M |
| Total Assets | $135.5M | $50.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.2M | $45.1M | ||
| Q3 25 | $53.5M | $30.8M | ||
| Q2 25 | — | $32.4M | ||
| Q1 25 | $31.5M | $41.8M | ||
| Q4 24 | $44.3M | $30.3M | ||
| Q3 24 | $44.1M | $36.6M | ||
| Q2 24 | — | $41.4M | ||
| Q1 24 | $44.1M | $47.2M |
| Q4 25 | $55.8M | $15.3M | ||
| Q3 25 | $73.8M | $6.0M | ||
| Q2 25 | — | $17.5M | ||
| Q1 25 | $57.2M | $5.1M | ||
| Q4 24 | $62.3M | $6.7M | ||
| Q3 24 | $63.9M | $34.3M | ||
| Q2 24 | — | $40.6M | ||
| Q1 24 | $65.0M | $46.1M |
| Q4 25 | $135.5M | $50.2M | ||
| Q3 25 | $155.0M | $36.1M | ||
| Q2 25 | — | $38.7M | ||
| Q1 25 | $137.2M | $48.2M | ||
| Q4 24 | $138.5M | $36.9M | ||
| Q3 24 | $137.3M | $40.4M | ||
| Q2 24 | — | $44.8M | ||
| Q1 24 | $148.4M | $51.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.9M | $-35.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.9M | $-35.3M | ||
| Q3 25 | $3.8M | $-6.2M | ||
| Q2 25 | — | $-10.3M | ||
| Q1 25 | $-1.3M | $-9.0M | ||
| Q4 24 | $-4.0M | $-25.6M | ||
| Q3 24 | $-5.8M | $-5.1M | ||
| Q2 24 | — | $-7.3M | ||
| Q1 24 | $1.4M | $-5.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.44× | — | ||
| Q3 24 | -2.19× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEG
| Management Service Base | $1.8M | 60% |
| Other | $1.2M | 40% |
IRD
Segment breakdown not available.
